XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Investments - Investment Portfolio at Cost and Fair Value (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Cost $ 48,875,505 $ 49,935,296
Fair Value $ 48,413,196 $ 48,908,608
Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 100.00% 100.00%
First lien debt    
Schedule of Investments [Line Items]    
Cost $ 43,712,868 [1],[2] $ 44,461,300 [3],[4]
Fair Value $ 43,280,219 [2] $ 43,710,812 [4]
First lien debt | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 89.40% 89.37%
Second lien debt    
Schedule of Investments [Line Items]    
Cost $ 1,891,517 $ 2,074,849 [3],[4]
Fair Value $ 1,779,485 $ 1,872,806 [4]
Second lien debt | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 3.68% 3.83%
Unsecured debt    
Schedule of Investments [Line Items]    
Cost $ 0 $ 17,583
Fair Value $ 0 $ 13,948
Unsecured debt | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 0.00% 0.03%
Structured Finance Investments    
Schedule of Investments [Line Items]    
Cost $ 409,268 [1],[2] $ 409,633 [3],[4]
Fair Value $ 395,026 [2] $ 365,269 [4]
Structured Finance Investments | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 0.81% 0.75%
Investments in joint ventures    
Schedule of Investments [Line Items]    
Cost $ 2,120,206 [1],[2] $ 2,232,706
Fair Value $ 2,151,389 [2] $ 2,188,394
Investments in joint ventures | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 4.44% 4.47%
Equity investments    
Schedule of Investments [Line Items]    
Cost $ 741,646 [1],[2] $ 739,225
Fair Value $ 807,077 [2] $ 757,379
Equity investments | Investments At Fair Value | Investment Type Concentration Risk    
Schedule of Investments [Line Items]    
% of Total Investments at Fair Value 1.67% 1.55%
[1] The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
[2] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Condensed Consolidated Schedule of Investments) are denominated in dollars. As of September 30, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Swiss Francs (CHF), Danish Krone (DKK), Swedish Krona (SEK), Norwegian Krone (NOK), and New Zealand Dollars (NZD). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.
[3] The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
[4] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December 31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Swiss Francs (CHF), Danish Krone (DKK), Swedish Krona (SEK), Norwegian Krone (NOK), and New Zealand Dollars (NZD). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.